Most neurons in your brain and spinal cord are permanently locked out of the cell division process. Unlike skin cells, blood cells, or liver cells, which replace themselves throughout your life, mature neurons entered a state of permanent retirement from division before you were born. When they die from injury or disease, the body has almost no way to grow new ones to take their place. This comes down to a combination of molecular locks inside the neurons themselves, a hostile surrounding environment, and what appears to be an evolutionary trade-off between repair and stability.
Neurons Are Permanently Retired From Division
The most fundamental reason damaged neurons aren’t replaced is that mature neurons cannot divide. During brain development, neural progenitor cells divide rapidly to produce the roughly 86 billion neurons you’re born with. But as each neuron matures, it permanently exits the cell cycle, entering what scientists call a “post-mitotic” state. This isn’t a temporary pause. It’s a one-way door.
Several molecular brakes enforce this exit. A family of proteins called the retinoblastoma (Rb) family is essential for pushing developing neurons into their final, non-dividing state. Without these proteins functioning properly, neurons fail to differentiate correctly and instead die. Once a neuron has matured, another protein called necdin, found exclusively in post-mitotic cells, helps maintain permanent mitotic arrest. These proteins work together to ensure that once a neuron commits to its specialized role, it never attempts to divide again.
This arrangement makes a certain kind of sense. A mature neuron is an extraordinarily complex cell. It can extend a single axon over a meter long, form thousands of synaptic connections with other neurons, and maintain precise electrical signaling patterns. Dismantling all of that architecture to undergo cell division would be like tearing down a skyscraper to reuse the foundation. The cell’s entire identity is built around connectivity, not reproduction.
Neurons Spend Nearly All Their Energy on Signaling
Brain tissue is one of the most energy-hungry tissues in the body. Your brain accounts for about 2% of your body weight but uses roughly 20% of your oxygen and glucose. Within that budget, electrical signaling alone eats up to 75% of a neuron’s energy expenditure. Neurons are also extremely sensitive to even brief drops in oxygen or glucose supply, which is why a stroke causes damage within minutes.
This intense metabolic demand leaves very little room for the energy-intensive process of cell division. Duplicating DNA, assembling a second set of organelles, and physically splitting into two daughter cells requires a massive reallocation of resources. For a cell already running near its metabolic ceiling just to maintain normal function, that reallocation would be dangerous, both to the dividing cell and to the circuits it supports.
The Brain’s Environment Blocks Regrowth
Even if new neurons could somehow be produced, the adult brain actively discourages regrowth. When neurons in the central nervous system (the brain and spinal cord) are damaged, surrounding support cells called astrocytes rush to the injury site and form what’s known as a glial scar. This scar serves a useful short-term purpose: it walls off the damaged area, limits inflammation, and prevents further tissue destruction. But it also creates a chemical barrier that blocks new axons from growing through.
The glial scar releases a group of molecules called chondroitin sulphate proteoglycans (CSPGs), which act like molecular “keep out” signs for growing nerve fibers. On top of that, the debris from damaged myelin (the insulating coating around nerve fibers) releases its own set of inhibitory molecules. At least five distinct inhibitors have been identified in myelin debris alone. Together, these signals create an environment where new neural connections simply cannot form, even when the raw biological materials are present.
The brain’s extracellular matrix, the structural scaffolding between cells, also differs from most other tissues. While skin and bone rely on collagen and elastin fibers to provide structure, the brain’s matrix is mainly composed of sugar-based molecules called glycosaminoglycans. This unusual composition means the brain lacks the fibrous “tracks” that help guide cell migration and regrowth in other tissues.
Peripheral Nerves Can Regenerate, but Brain Neurons Cannot
The contrast with the peripheral nervous system highlights just how hostile the brain environment is. Nerves outside the brain and spinal cord, like those running to your hands and feet, can regrow after injury. Peripheral axons regenerate at roughly 1 millimeter per day on average, though the rate varies by nerve. The radial nerve in the arm, for example, regrows at 4 to 5 mm per day, while the ulnar nerve manages about 1.5 mm per day.
This regeneration is possible because the peripheral nervous system has a fundamentally different support structure. Schwann cells, the glial cells of peripheral nerves, actively clear debris and lay down growth-promoting tracks for regrowing axons to follow. In the central nervous system, the equivalent cells (oligodendrocytes) do not perform this cleanup role, and the astrocytes that dominate the injury response produce inhibitory molecules instead of growth-promoting ones.
A Small Exception: The Hippocampus
The brain is not entirely incapable of producing new neurons. Two small regions retain the ability to generate neurons throughout adulthood. The subventricular zone, lining the brain’s fluid-filled ventricles, produces a small number of neurons that contribute to smell-related circuits, though this process is rudimentary in humans. More significantly, the subgranular zone of the hippocampus, a region critical for memory and learning, generates an estimated 700 new neurons per day in the adult human brain, based on carbon-dating studies by Jonas Frisén’s lab.
These new hippocampal neurons are thought to play a role in forming new memories and protecting the brain against stress-related damage. But 700 neurons per day is a tiny fraction of the billions already present, and this production is limited to one specific brain region. It doesn’t help replace neurons lost to a stroke in the motor cortex or degeneration in Parkinson’s disease. The vast majority of the brain remains a no-growth zone.
Replacing Neurons Could Erase What They Stored
There may be a deeper reason the brain evolved to sacrifice repair for permanence. Your memories, personality, learned skills, and habits are all encoded in the specific pattern of connections between neurons. Each synapse has been strengthened or weakened over years of experience. Replacing a neuron means destroying its unique connection profile and inserting a blank cell that would need to somehow rebuild thousands of precise synaptic links.
Think of it this way: replacing a transistor in a computer chip with a brand-new one doesn’t restore the data that was stored in the circuit. The information lived in the specific configuration, not the hardware itself. The brain faces the same problem. A new neuron in the hippocampus can be integrated because the hippocampus is designed to incorporate fresh cells into its circuits. But most brain regions have no such mechanism, and swapping in new cells would disrupt the very patterns that make you who you are.
Experimental Approaches to the Problem
Researchers are pursuing two main strategies to work around these biological barriers. The first involves transplanting neurons grown from stem cells. A Phase I/II trial published in April 2025 reported that dopamine-producing neurons derived from donor stem cells survived transplantation into the brains of Parkinson’s disease patients, produced dopamine, and did not form tumors. A separate ongoing trial at Mass General Brigham is testing neurons grown from a patient’s own blood-derived stem cells, which would eliminate the need for immune-suppressing drugs. Additional trials are targeting both Parkinson’s disease and ALS.
The second strategy skips transplantation entirely by converting existing brain cells into neurons on the spot. Astrocytes, the same support cells that form inhibitory scars, share developmental origins with neurons and can be reprogrammed. Researchers have successfully converted astrocytes into functional neurons by introducing specific neural transcription factors or by knocking down a single protein called PTB. This approach has shown promise in mouse models of stroke, turning scar-forming cells into replacement neurons right at the injury site.
Both strategies face significant hurdles. Transplanted neurons must integrate into existing circuits without disrupting them. Reprogrammed astrocytes must mature into the correct neuron type for their location. And in both cases, the hostile chemical environment of the injured brain must be overcome. But the fact that these approaches work at all in early trials suggests the brain’s resistance to neuron replacement, while formidable, is not absolute.